Drug recall
Apheresis Platelets, Platelet Additive Solution Added, Leukocytes Reduced
FDA recall event 89298 · Class II · The American National Red Cross - Southern Region
Key facts
| Event ID | 89298 |
|---|---|
| Recall numbers | B-0144-2022 |
| Recalling firm | The American National Red Cross - Southern Region |
| Product type | Biologics |
| Products | Apheresis Platelets, Platelet Additive Solution Added, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Plateletpheresis, not meeting product specifications, was distributed. |
| Initiation date | Oct 18, 2021 |
| Report date | Jan 26, 2022 |
| Termination date | Jan 18, 2022 |
| City | Douglasville |
| State | GA |
| Country | United States |
| FEI number | 1073000 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: